Nanofibrillar cellulose wound dressing supports the growth and characteristics of human mesenchymal stem/stromal cells without cell adhesion coatings.
Adipose-derived mesenchymal stem/stromal cell
Cell scaffold
Cell transplantation
Nanofibrillar cellulose
Regenerative medicine
Wound healing
Journal
Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581
Informations de publication
Date de publication:
23 09 2019
23 09 2019
Historique:
received:
07
07
2019
accepted:
22
08
2019
revised:
15
08
2019
entrez:
25
9
2019
pubmed:
25
9
2019
medline:
28
7
2020
Statut:
epublish
Résumé
In the field of regenerative medicine, delivery of human adipose-derived mesenchymal stem/stromal cells (hASCs) has shown great promise to promote wound healing. However, a hostile environment of the injured tissue has shown considerably to limit the survival rate of the transplanted cells, and thus, to improve the cell survival and retention towards successful cell transplantation, an optimal cell scaffold is required. The objective of this study was to evaluate the potential use of wood-derived nanofibrillar cellulose (NFC) wound dressing as a cell scaffold material for hASCs in order to develop a cell transplantation method free from animal-derived components for wound treatment. Patient-derived hASCs were cultured on NFC wound dressing without cell adhesion coatings. Cell characteristics, including cell viability, morphology, cytoskeletal structure, proliferation potency, and mesenchymal cell and differentiation marker expression, were analyzed using cell viability assays, electron microscopy, immunocytochemistry, and quantitative or reverse transcriptase PCR. Student's t test and one-way ANOVA followed by a Tukey honestly significant difference post hoc test were used to determine statistical significance. hASCs were able to adhere to NFC dressing and maintained high cell survival without cell adhesion coatings with a cell density-dependent manner for the studied period of 2 weeks. In addition, NFC dressing did not induce any remarkable cytotoxicity towards hASCs or alter the morphology, proliferation potency, filamentous actin structure, the expression of mesenchymal vimentin and extracellular matrix (ECM) proteins collagen I and fibronectin, or the undifferentiated state of hASCs. As a result, NFC wound dressing offers a functional cell culture platform for hASCs to be used further for in vivo wound healing studies in the future.
Sections du résumé
BACKGROUND
In the field of regenerative medicine, delivery of human adipose-derived mesenchymal stem/stromal cells (hASCs) has shown great promise to promote wound healing. However, a hostile environment of the injured tissue has shown considerably to limit the survival rate of the transplanted cells, and thus, to improve the cell survival and retention towards successful cell transplantation, an optimal cell scaffold is required. The objective of this study was to evaluate the potential use of wood-derived nanofibrillar cellulose (NFC) wound dressing as a cell scaffold material for hASCs in order to develop a cell transplantation method free from animal-derived components for wound treatment.
METHODS
Patient-derived hASCs were cultured on NFC wound dressing without cell adhesion coatings. Cell characteristics, including cell viability, morphology, cytoskeletal structure, proliferation potency, and mesenchymal cell and differentiation marker expression, were analyzed using cell viability assays, electron microscopy, immunocytochemistry, and quantitative or reverse transcriptase PCR. Student's t test and one-way ANOVA followed by a Tukey honestly significant difference post hoc test were used to determine statistical significance.
RESULTS
hASCs were able to adhere to NFC dressing and maintained high cell survival without cell adhesion coatings with a cell density-dependent manner for the studied period of 2 weeks. In addition, NFC dressing did not induce any remarkable cytotoxicity towards hASCs or alter the morphology, proliferation potency, filamentous actin structure, the expression of mesenchymal vimentin and extracellular matrix (ECM) proteins collagen I and fibronectin, or the undifferentiated state of hASCs.
CONCLUSIONS
As a result, NFC wound dressing offers a functional cell culture platform for hASCs to be used further for in vivo wound healing studies in the future.
Identifiants
pubmed: 31547864
doi: 10.1186/s13287-019-1394-7
pii: 10.1186/s13287-019-1394-7
pmc: PMC6757411
doi:
Substances chimiques
Cellulose
9004-34-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
292Références
Eur J Pharm Sci. 2014 Dec 18;65:79-88
pubmed: 25245005
Cytotherapy. 2017 Dec;19(12):1548-1550
pubmed: 28986173
Organogenesis. 2015;11(4):183-206
pubmed: 26652928
Stem Cell Res Ther. 2013 Feb 15;4(1):17
pubmed: 23415114
Stem Cell Res Ther. 2010 Mar 15;1(1):2
pubmed: 20504283
Int J Mol Sci. 2014 Jan 28;15(2):2075-86
pubmed: 24477265
Stem Cells Int. 2012;2012:465259
pubmed: 22448172
Regen Med. 2016 Apr;11(3):245-60
pubmed: 26986810
Stem Cells Dev. 2009 Oct;18(8):1201-10
pubmed: 19226222
Front Immunol. 2014 Nov 04;5:556
pubmed: 25414703
J Control Release. 2012 Dec 28;164(3):291-8
pubmed: 22776290
FASEB J. 2013 Apr;27(4):1351-61
pubmed: 23254340
Stem Cell Rev Rep. 2018 Feb;14(1):43-57
pubmed: 28884292
J Mater Sci Mater Med. 2017 Jan;28(1):9
pubmed: 27896599
Stem Cells Int. 2012;2012:920581
pubmed: 23715383
Exp Mol Med. 2013 Jan 10;45:e2
pubmed: 23306700
Biomaterials. 2015 Aug;61:316-26
pubmed: 26026844
Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:905-918
pubmed: 30889765
Cell Transplant. 2011;20(2):205-16
pubmed: 20719083
J Int Med Res. 2009 Sep-Oct;37(5):1528-42
pubmed: 19930861
Biores Open Access. 2014 Aug 1;3(4):137-49
pubmed: 25126478
Cell Transplant. 2011;20(5):693-706
pubmed: 21176394
Curr Opin Biotechnol. 2012 Dec;23(6):978-83
pubmed: 22682584
J Control Release. 2016 Dec 28;244(Pt B):292-301
pubmed: 27491880
J Dermatol Sci. 2007 Oct;48(1):15-24
pubmed: 17643966
Biomaterials. 2014 Jun;35(19):5110-21
pubmed: 24698520
Int J Pharm. 2017 Oct 30;532(1):269-280
pubmed: 28888974
Biotechnol J. 2018 Feb;13(2):
pubmed: 29193872
Biotechnol Adv. 2011 Nov-Dec;29(6):739-67
pubmed: 21821113
Ann Plast Surg. 2009 Mar;62(3):317-21
pubmed: 19240532
Chemosphere. 2017 Mar;171:671-680
pubmed: 28061425
Tissue Eng. 2001 Apr;7(2):211-28
pubmed: 11304456
Adv Wound Care (New Rochelle). 2020 Apr 1;9(4):199-210
pubmed: 32117583
Angew Chem Int Ed Engl. 2011 Jun 6;50(24):5438-66
pubmed: 21598362
Stem Cells Dev. 2014 Feb 15;23(4):380-92
pubmed: 24188453
J Cell Physiol. 2006 Jul;208(1):64-76
pubmed: 16557516
Int J Biochem Cell Biol. 2018 Feb;95:132-142
pubmed: 29307663
J Surg Res. 2018 Sep;229:243-253
pubmed: 29936997
Stem Cell Rev Rep. 2017 Apr;13(2):267-277
pubmed: 28120159
Cytotechnology. 2007 Sep;55(1):31-9
pubmed: 19002992
J Anat. 2008 Nov;213(5):520-30
pubmed: 19014359
Stem Cells. 2006 Feb;24(2):376-85
pubmed: 16322640
Biomed Pharmacother. 2018 Nov;107:625-633
pubmed: 30118878
Stem Cell Res Ther. 2010 Nov 11;1(5):34
pubmed: 21092149
Sci Rep. 2017 May 18;7(1):2098
pubmed: 28522871
Fed Regist. 1998 Nov 6;63(215):60009-10
pubmed: 10187389
BMC Med. 2015 Aug 12;13:186
pubmed: 26265166
Biomater Sci. 2018 May 1;6(5):1109-1119
pubmed: 29528341
Sci Rep. 2018 Jun 20;8(1):9401
pubmed: 29925980
Cell. 1996 Feb 9;84(3):345-57
pubmed: 8608588
Circulation. 2003 Aug 19;108(7):863-8
pubmed: 12900340
Stem Cells Dev. 2013 Jan 15;22(2):330-9
pubmed: 22920587
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Biomaterials. 2011 Jan;32(1):119-27
pubmed: 21074262
J Invest Dermatol. 2011 Jul;131(7):1559-67
pubmed: 21451545
Exp Mol Med. 2017 Jun 16;49(6):e346
pubmed: 28620221
J Surg Res. 2017 Sep;217:63-74
pubmed: 28595815
Int J Nanomedicine. 2018 Jul 04;13:3867-3881
pubmed: 30013341
Eur J Pharm Biopharm. 2012 Oct;82(2):308-15
pubmed: 22750440
J Dent Res. 2010 Mar;89(3):219-29
pubmed: 20139336
Exp Cell Res. 2010 Aug 15;316(14):2213-9
pubmed: 20471978
Stem Cell Res Ther. 2018 Jan 31;9(1):21
pubmed: 29386050
Plast Reconstr Surg. 2018 Jul;142(1):136-147
pubmed: 29649060
Tissue Eng Part C Methods. 2014 Dec;20(12):972-83
pubmed: 24628423
Cytotechnology. 2016 Aug;68(4):891-906
pubmed: 25777046
Biol Blood Marrow Transplant. 2012 Jun;18(6):822-40
pubmed: 21963621
Int J Mol Sci. 2017 Oct 02;18(10):
pubmed: 28974046
Ann Plast Surg. 2012 Dec;69(6):656-62
pubmed: 23154338
Biomaterials. 2016 Mar;82:208-20
pubmed: 26763735
Plast Reconstr Surg. 2018 Apr;141(4):892-901
pubmed: 29256998
Cell Immunol. 2018 Apr;326:68-76
pubmed: 28919171
Ann Plast Surg. 2018 May;80(5):572-580
pubmed: 29443833
J Tissue Eng Regen Med. 2016 Feb;10(2):E90-E100
pubmed: 23418160
Stem Cells Transl Med. 2014 Oct;3(10):1220-30
pubmed: 25122689